Patient Blood Management in Cardiac Surgical Patients: the ICARUS-2 Study

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Observational
SUMMARY

The ICARUS 2 study has the general objective of collecting data in patients undergoing cardiac surgery; in our centre, in order to optimize and improve hemoglobin values, a team of haematologists, assisted by cardio anesthetists and cardiac surgeons, will evaluate the blood tests of patients scheduled for elective cardiac surgery in order to correct any states of hypoferritinemia (low iron in the blood) to promote recovery from blood losses related to cardiac surgery. This objective is strongly encouraged by the good use of blood programs currently in force at our foundation. In particular, the research presented here intends to demonstrate a reduction in the number of intra- and post-operative transfusions.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• \- all adult patients scheduled for elective cardiac surgery

Locations
Other Locations
Italy
Fondazione Policlinico Gemelli IRCCS
RECRUITING
Roma
Contact Information
Primary
filippo Corsi, MD
filippo.corsi@policlinicogemelli.it
+390630151
Backup
Luciana Teofili, PhD, MD
+390630151
Time Frame
Start Date: 2025-02-24
Estimated Completion Date: 2027-02-28
Participants
Target number of participants: 464
Treatments
Prospectic cohort
patients scheduled for cardiac surgery who fulfil the inclusion criteria
retrospective cohort ICARUS 1
patients scheduled for cardiac surgery (2021) with a known iron status, treated if indicated 1 or 2 days before surgery with iron supplementation.
retrospective cohort
patients scheduled for cardiac surgery (2019-2020)with an unknown iron status and never treated with iron supplementation
Related Therapeutic Areas
Sponsors
Leads: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

This content was sourced from clinicaltrials.gov